Gads is a member of the family of SH2 and SH3 domain containing adaptor proteins that is expressed speci®cally in hematopoietic cells and functions in the coordination of tyrosine kinase mediated signal transduction. Gads plays a critical role in signalling from the T cell receptor by promoting the formation of a complex between SLP-76 and LAT. This complex couples the T cell receptor to Ras through a novel pathway involving PLC-g1, Tec family kinases, and RasGRP. Studies with Gadsde®cient mice have highlighted its importance for thymocyte proliferation during T cell maturation. Emerging evidence suggests that Gads may also play additional roles in antigen-receptor signalling and receptor tyrosine kinase mediated signalling in other hematopoietic lineages. Gads is a unique member of the Grb2 adaptor family, because its activity can be regulated by caspase cleavage. Gads nucleates multiprotein complexes that are required for tyrosine kinasedependent signalling in immune cells and may also represent a point of modulation for these pathways through the activation of caspase-dependent signalling events. Oncogene (2001) 20, 6284 ± 6290.
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The Grb2 family of adaptor proteins ± Grb2, Grap, and Gads
One of the best known and characterized adaptors is the evolutionarily conserved Grb2 (Growth factor receptor bound-2) protein that plays an essential role in the activation of the Ras pathway by growth factor receptors (Clark et al., 1992; Lowenstein et al., 1992) . Grb2 contains only SH2 (Src homology 2) and SH3 (Src homology 3) domains with the arrangement SH3-SH2-SH3. The SH2 domain of Grb2 binds to the consensus motif pY-X-N (where pY is phosphotyrosine, and X is any amino acid) found in tyrosine-phosphorylated proteins such as activated growth factor receptors, the docking proteins Shc and LAT (Linker in activated T cells), and oncogenic tyrosine kinases such as Bcr ± Abl (Buday, 1999) . The SH3 domains of Grb2 bind to proline rich sequences in several signalling enzymes most notably those found in the guanine nucleotide exchange factor Sos, which functions to activate the Ras signalling pathway (Buday and Downward, 1993; Egan et al., 1993; Rozakis-Adcock et al., 1993) . The essential function of Grb2 in coupling tyrosine kinases to the activation of Ras has been demonstrated genetically in C. elegans, Drosophila and mice (Cheng et al., 1998; Clark et al., 1992; Olivier et al., 1993) . In vertebrates several Grb2-related genes have been identi®ed. Grap (Grb2-related adaptor protein) is closely related to Grb2 both in terms of its amino acid sequence and the speci®city of its SH2 and SH3 domains, however Grap expression is restricted to cells of hematopoietic origin (Feng et al., 1996; Trub et al., 1997) (Figure 1 ). While Grb2 is essential for early embryonic development, the function of Grap appears to be redundant since Grap null mice display no apparent phenotype (Cheng et al., 1998) .
The focus of this review is a recent addition to the Grb2 family, the Gads/Mona/Grap2/GrpL/Grf40 hematopoeitic-speci®c adaptor, which was cloned simultaneously by ®ve dierent groups, and hence has acquired as many names (Asada et al., 1999; Bourette et al., 1998; Law et al., 1999; Liu and McGlade, 1998; Qiu et al., 1998) . Gads was identi®ed in an expression screening approach using phosphopeptides corresponding to the Grb2-binding sites on the docking protein Shc (Liu and McGlade, 1998) . Three dierent groups identi®ed Gads in yeast two-hybrid screens using Gab1, AMSH or the activated M-CSF receptor as bait (Asada et al., 1999; Bourette et al., 1998; Qiu et al., 1998) . Gads was also identi®ed by random sequencing of cDNA clones from a lymphoid library (Law et al., 1999) . The Gads cDNA encodes a protein of 322 amino acids (*38 kDa), with a central SH2 domain and linker region¯anked by amino-and carboxy-terminal SH3 domains. The linker region of Gads is 120 amino acids, contains proline-rich stretches and has no signi®cant homology to any known proteins in the Genbank database. Gads is most highly expressed in T cells and its role in TCR (T cell receptor)-mediated signalling events has been intensively studied (Asada et al., 1999; Law et al., 1999; Liu et al., 1999 Liu et al., , 2000 Ma et al., 2001) . amino-terminal variable ligand-binding domain and a membrane proximal constant region and belongs to the immunoglobulin (Ig) superfamily (Gobel and Bolliger, 2000) . The TCR utilizes its transmembrane region to associate with the CD3 complex, which is present as two separate heterodimers of CD3g-CD3e, CD3e-CD3d, and a TCR-z homodimer (Gobel and Bolliger, 2000) . The cytoplasmic domains of each of the CD3 chains contain one ITAM (immunoreceptor tyrosinebased activation sequence motif), while the TCR-z chain contains three ITAMs, and these collectively serve as the signal-transducing unit for the TCR. The engagement of the TCR-CD3 complex activates src family p56 lck and p59 fyn tyrosine kinases that rapidly phosphorylate the ITAM sequences (Gobel and Bolliger, 2000) . Tyrosine-phosphorylation of the z chain ITAMs establishes a binding site for the tandem SH2 domain-containing protein kinase, Zap-70 (Cantrell, 1996; Weiss and Littman, 1994) . Activated src family and ZAP-70 tyrosine kinases phosphorylate downstream substrates such as enzymes and adaptor proteins, leading to activation of signal transduction pathways required for T cell activation (Cantrell, 1996; Myung et al., 2000; Weiss and Littman, 1994) .
Both ubiquitously-expressed and hematopoietic-speci®c adaptor proteins play an important role in collecting and bifurcating signals downstream of the TCR by nucleating multiprotein signalling complexes (Myung et al., 2000) . Two central adaptor proteins, LAT and SLP-76 (reviewed in this issue), are rapidly tyrosine-phosphorylated in response to TCR engagement, and are collectively involved in coordinating activation of the Ras-Erk pathway, the mobilization of Ca
2+
, and the rearrangement of the cytoskeleton, events that are essential for T cell eector responses. Although SLP-76 was originally identi®ed as a Grb2-binding protein, attempts to con®rm this association in vivo were unsuccessful (Jackman et al., 1995; Reif et al., 1994) . Soon after its identi®cation, it was recognized that Gads rather than Grb2 was the major in vivo binding partner of SLP-76 (Asada et al., 1999; Law et al., 1999; Liu et al., 1999) . Simultaneously, Gads was also shown to bind a tyrosine-phosphorylated protein of 36 kDa that was identi®ed as LAT (Asada et al., 1999; Law et al., 1999; Liu et al., 1999) .
Further analysis con®rmed that Gads constitutively associates with SLP-76 through its carboxy-terminal SH3 domain and, following TCR engagement, Gads binds to tyrosine-phosphorylated LAT through its SH2 domain (Asada et al., 1999; Law et al., 1999; Liu et al., 1999) . The presence of a trimolecular SLP-76-Gads-LAT complex in T cells prompted investigation into its potential function in TCR activation using the NFATluciferase and IL-2-luciferase reporter systems (distal readouts for TCR activation) in Jurkat T cells (Asada et al., 1999; Law et al., 1999; Liu et al., 1999) . Although over-expression of Gads alone has relatively little in¯uence on NFAT activation, coexpression with SLP-76 leads to a synergistic increase in activation, suggesting that Gads and SLP-76 function in a common signalling pathway (Asada et al., 1999; Law et al., 1999; Liu et al., 1999) . Gads containing a point mutation in the SH2 domain, which abrogates its association with tyrosine-phosphorylated LAT, does not synergize with SLP-76 to activate NFAT, and appears to have a dominant-negative eect, presumably due to uncoupling of SLP-76 from LAT (Asada et al., 1999; Liu et al., 1999) . Taken together, these observations implicate Gads as a mediator for crosstalk between SLP-76 and LAT complexes, which function downstream of the TCR leading to NFAT activation and IL-2 induction.
While Ras has been established as a critical downstream eector of TCR signalling, the mechanisms leading to its activation have remained somewhat uncertain (Downward et al., 1990 Rayter et al., 1992; Woodrow et al., 1993) . The classic model for the activation of the Ras pathway following TCR engagement, was developed from research in growth factor signalling, and postulated that the membrane localization of Grb2-Sos induced by LAT was the key mechanism leading to Ras activation Reif et al., 1994; Sieh et al., 1994; Weber et al., 1998; Zhang et al., 1998) . However, loss of ecient PLC-g1 recruitment to LAT in Jurkat T cells inhibits the phosphorylation and presumably the activation of PLC-g1, resulting in greatly impaired Erk activation, despite the presence of LAT-associated Grb2-Sos complexes (Zhang et al., 2000) . This result implied that PLC-g1 is a primary means of regulating the Ras- Figure 1 The Grb2 family members. A schematic representation of the Grb2 family members ± Grb2, Grap, and Gads ± is shown. The region between the Gads SH2 domain and carboxy-terminal SH3 domain is termed the`linker region'. The expression pattern, and phenotype arising from gene targeting experiments in mice is listed alongside the respective Grb2 family members Erk pathway in T cells. Additionally, it was known that certain Tec family kinases (Rlk/Txk and Itk) inducibly associate with SLP-76 in response to TCR activation, and function to phosphorylate and activate PLC-g1 (Bunnell et al., 2000; Schneider et al., 2000; Su et al., 1999) It was thus proposed that upon TCR engagement, Gads mediates the activation of PLC-g1 by Itk and Rlk/Txk through the colocalization of LAT-PLC-g1 and SLP-76-Itk (or SLP-76-Rlk/Txk) complexes (Bunnell et al., 2000) (Figure 2) .
A recently discovered guanine nucleotide exchange factor, RasGRP, is activated by DAG (diacylglycerol), a second messenger generated from the hydrolysis of PIP 2 (phosphatidylinositol 4,5 bisphosphate) by PLCg1 (Kawasaki et al., 1998; Roose and Weiss, 2000) . Since RasGRP has been shown to be a major Ras activator in T cells, RasGRP may serve as a direct link between PLC-g1 and Ras activation downstream of the TCR (Dower et al., 2000; Ebinu et al., 2000; Roose and Weiss, 2000; Topham and Prescott, 2001) . Furthermore, this model can explain the requirement of the SLP-76-Gads-LAT complex in mediating Ras activation through a PLC-g1-dependent pathway.
The recruitment of Grb2-Sos to LAT would provide an alternative route for Ras activation, perhaps utilized to varying degrees by distinct T lymphocyte subpopulations. The extent to which these two pathways are used may provide selective modulation of the temporal and quantitative aspects of Ras activation that are required to yield speci®c cellular outcomes.
Gads in T cell development
The development of thymocytes into mature T cells is classi®ed into three stages of increasing maturity, double negative (DN), double positive (DP), and single positive (SP), based upon their surface expression of the CD4 and CD8 TCR coreceptors (e.g., CD4 + CD8
+ would be DP), and the DN stage can be further subdivided into four discrete stages (pro-T1 to pro-T4) based upon CD25 and CD44 surface expression (Zuniga-P¯ucker and Lenardo, 1996) . At the pro-T3 stage, the TCR-b chain gene begins rearrangement leading to expression of the b chain with the pre-Ta chain, on the cell surface as a Figure 2 Model for Gads in TCR signalling. Engagement of the TCR leads to rapid activation of Lck, Fyn (not shown) and ZAP-70 kinases, and phosphorylation of key adaptor proteins including LAT and SLP-76. LAT nucleates Grb2-Sos, PLC-g1 and Gads-SLP-76-Itk complexes. Ecient activation of PLC-g1 requires tyrosine-phosphorylation by Tec family kinases. Gads promotes crosstalk between LAT and SLP-76 signalling complexes, by colocalizing LAT-bound PLC-g1 and SLP-76-bound Tec kinases, ensuring optimal activation of PLC-g1. This leads to DAG and IP 3 production, which are required for activation of RasGRP and Ca 2+ -mediated nuclear translocation of NFAT, respectively. RasGRP activates Ras resulting in activation of both additional Ras eectors and the Raf ± Erk pathway that promote formation of the AP-1 complex. The recruitment of Grb2-Sos to LAT would provide an alternative route to Ras activation, perhaps utilized to varying degrees by distinct T lymphocyte subpopulations. SLP-76 is also likely involved in mediating cytoskeletal changes through its interactions with Nck, Vav, and SLAP-130. NFAT and AP-1 are critical transcription factors for driving expression of the IL-2 gene covalently-linked pre-TCR. The pre-TCR co-operates with the CD3 chains to initiate signalling events that culminate in the abrogation of further TCR-b gene rearrangement, initiation of TCR-a gene rearrangement, and extensive cell division (Ellmeier et al., 1999; Zuniga-P¯ucker and Lenardo, 1996) . Upon productive rearrangement of the TCR-a gene, the mature ab-TCR-is expressed on the cell surface, and thymocytes undergo positive or negative selection based upon the speci®city of their mature TCR and transit into the CD8 + or CD4 + SP lineage, which is restricted by MHC class I or II, respectively (Sebzda et al., 1999) .
Generation of Gads-de®cient mice by gene targeting revealed an essential role for Gads in the development of T lymphocytes but not other hematopoietic lineages (Yoder et al., 2001) . Gads-de®cient DN thymocytes exhibit a severe block in proliferation at the pro-T3 stage, but still dierentiate into mature T cells (Yoder et al., 2001 ). Positive and negative selection of thymocytes is also impaired in Gads-de®cient mice (Yoder et al., 2001) . Biochemical analyses revealed that SLP-76 fails to form a complex with LAT in the absence of Gads (Yoder et al., 2001) . Consistent with the model of Gads adaptor function (Figure 2) , uncoupling of SLP-76 and LAT resulted in a substantial reduction in PLC-g1 phosphorylation, and a corresponding impairment in Ca 2+ mobilization in response to TCR engagement (Yoder et al., 2001) . Recently, mice with transgenic expression of a dominant-negative form of Gads (lacking the SH2 domain) were observed to have similar eects on T cell development, including impairment of thymocyte progression past the pro-T3 stage (Kikuchi et al., 2001) . In the transgenic mice, the defect in thymocyte development also correlated with severely reduced PLC-g1 phosphorylation, and notably, a concomitant reduction in Erk phosphorylation (Kikuchi et al., 2001) .
Both SLP-76 and LAT-de®cient mice exhibit a complete block in thymocyte dierentiation at the pro-T3 stage, presumably due to the absence of signalling from the pre-TCR Pivniouk et al., 1998; Zhang et al., 1999) . In contrast, Gads-de®cient thymocytes still dierentiate into mature T cells despite the block in proliferation at the pro-T3 stage (Yoder et al., 2001) . One explanation for the reduced severity of the Gads knockout phenotype may be that the loss of Gads selectively uncouples PLC-g1-dependent activation of Ras from other SLP-76-mediated signalling events. In addition, Gads-de®cient thymocytes retain the LAT-Grb2-Sos pathway, which may provide sucient levels of activated Ras to drive thymocyte dierentiation, but not to promote ecient proliferation. Clearly, Grb2 also plays an important and perhaps distinct role in thymocyte development, since its decreased expression, through haploid insuciency, selectively reduces JNK and p38 but not Erk activation, and impairs negative but not positive selection (Gong et al., 2001 ).
Gads binding speci®city
Although it has never been directly investigated, most of the experimental data (including the methods used for the initial identi®cation of Gads) indicate that the binding speci®city of the Gads SH2 domain is similar to the Grb2 SH2 domain, which has a preference for the consensus motif pY-X-N-X. For example, Gads was isolated in a phosphopeptide expression screen to identify SH2 domain-containing proteins that could bind to the Grb2 binding site on Shc (Liu and McGlade, 1998) . Gads was also cloned on the basis of its association with the autophosphorylated M-CSF receptor, and this interaction was mapped to the Grb2 binding site (Bourette et al., 1998) . Subsequent work in T cells revealed that tyrosine-phosphorylated LAT is a major physiological binding partner for the Gads SH2 domain (Asada et al., 1999; Law et al., 1999; Liu et al., 1999) . Gads bound to two of the ®ve Y-X-N-X sites on tyrosine-phosphorylated LAT, while Grb2 bound to the three distal motifs, including the two sites that also mediate association with Gads (Zhang et al., 2000) . In this case, the binding of Gads to LAT appears to be more selective, suggesting that there may be subtle dierences in their binding speci®city. Gads has also been reported to associate with other proteins containing a pY-X-N-X motif, including Bcr ± Abl, CD28, SHP-2, and c-kit (Ellis et al., 2000; Law et al., 1999; Liu and McGlade, 1998) . However, the physiological signi®cance of these interactions has not been determined.
In contrast to the similarity between the Grb2 and Gads SH2 domain-binding speci®city, the SH3 domain targets bound by these adaptors are distinct. For example, Gads does not bind in vivo to any of the well characterized Grb2-binding partners such as Sos, Cbl, and Sam68 (Liu and McGlade, 1998) . In T cells, SLP-76 is a major target of the Gads carboxy-terminal SH3 domain (Asada et al., 1999; Law et al., 1999; Liu et al., 1999) . The Gads binding site was mapped to a region of SLP-76 (between amino acids 224 ± 244), which does not contain a canonical P-X-X-P SH3 domain binding consensus motif (Liu et al., 1999) . Interestingly, a highly related sequence to this SLP-76 region which is found in Gab1 and Gab2, also mediates in vitro binding to the carboxy-terminal SH3 domains of both Grb2 and Gads (Lock et al., 2000) . Further analysis indicates that these interactions are likely mediated by a novel consensus motif P-X 3 -R-X 2 -X-P (Lewitzky et al., 2001; Lock et al., 2000) . While the carboxyterminal SH3 domains of both Grb2 and Gads appear to bind to this novel motif in vitro, this binding cannot be recapitulated in vivo, where it has been shown that even in the absence of Gads, Grb2 does not associate with SLP-76 (Cheng et al., 1998) . It remains to be determined whether this speci®city is in¯uenced by additional factors such as dierences in the subcellular localization or relative anities of these adaptor proteins for their targets.
The carboxy-terminal SH3 domain of Gads also associates with HPK1 (Liu et al., 2000; Ma et al., 2001) and AMSH (Asada et al., 1999 and S Liu, D Berry and J McGlade, unpublished observations) . The Gads binding site on HPK1 was previously shown to be utilized in vitro by the Grb2 amino-terminal SH3 domain (Ana® et al., 1997; Kiefer et al., 1996) Accordingly, dierences in subcellular localization or binding anities may contribute towards the regulation of Gads versus Grb2 binding to HPK1.
The amino-terminal SH3 domain of Grb2 mediates its interaction with classic P-X-X-P SH3 binding consensus motifs in target proteins such as Sos (Buday and Downward, 1993; Buday et al., 1994; Li et al., 1993; Rozakis-Adcock et al., 1993; Sastry et al., 1995; Simon and Schreiber, 1995) . In comparison, no binding partners of the amino terminal SH3 domain of Gads have been identi®ed to date. In addition, abrogation of the amino terminal SH3 domain function does not appear to have a measurable eect on Gads binding to its known binding partners, nor does it appear to be required for Gads ability to augment SLP-76 mediated NF-AT activation. Therefore the role of this domain remains a mystery.
Role of the linker region
Gads possesses a proline and glutamine-rich linker region between the SH2 domain and carboxy-terminal SH3 domain that distinguishes it from other members of the Grb2 family. Recently it was discovered that the linker region of Gads contains a caspase 3 cleavage site D-I-N-D (amino acids 232 ± 235) (Berry et al., 2001; Yankee et al., 2001) . Upon CD95 (Fas) ligation of T cells, caspase 3 cleaves Gads into two fragments, one possessing the amino-terminal SH3 domain and the SH2 domain of Gads, and the other containing the carboxy-terminal SH3 domain of Gads. The binding speci®city of the domains within each fragment is retained after cleavage of Gads (Berry et al., 2001) . Therefore the cleavage of Gads following CD95 ligation might perturb TCR signalling by uncoupling SLP-76 and LAT, thereby disrupting downstream pathways. Indeed, it was reported that both Jurkat T cells and the MP-1 B cell line become desensitized to antigen receptor activation following ligation of CD95 (Yankee et al., 2001) . Further support for a suppressive role for Gads cleavage in antigen signalling comes from the fact that over-expression of either of the Gads cleavage products inhibits NFAT activation in Jurkat T cells (Berry et al., 2001) .
Gads in other hematopoietic lineages
In addition to T cells, Gads is expressed in other hematopoietic cells, including mast cells, monocytes, macrophage, megakaryocytes, platelets, and natural killer cells (Asada et al., 1999; Bourette et al., 1998; Law et al., 1999; Liu et al., 1999) . This expression pattern is similar to that of the Gads binding partners SLP-76 and LAT Zhang et al., 1998) . It stands to reason that Gads has a role in these cell types similar to the one it plays in T cells, linking SLP-76 to membrane-associated LAT upon antigen receptor activation. In fact, the Gads-SLP-76-LAT complex can be detected upon activation of the GPVI Ig receptor of platelets (Asazuma et al., 2000) or the Fce receptor of primary mast cells and cells of the RBL-2H3 mast cell line (unpublished observations, S Liu, D Berry and CJ McGlade). However, the functional signi®cance of the SLP-76-Gads-LAT complex has not been completely evaluated in these cell types. Some insight into the role of Gads in platelet function can be derived from Gads-de®cient mice, since they do not exhibit the severe hemorrhaging observed in SLP-76-de®cient mice due to defective platelet aggregation and secretion, and suggests that an essential role for Gads in platelet function is unlikely (Yoder et al., 2001) . While mast cells develop normally in Gads-de®cient mice, preliminary results suggest that Gads, like SLP-76 and LAT plays an important role in signalling from the Fce receptor in mature mast cells (Alec Cheng, personal communication,) .
It has been reported that Gads expression is detectable in certain pre-B and B cell lines and naive B cells (G Mouchiroud, personal communication; Law et al., 1999) , but not in germinal center B cells. However, B cell development is normal in Gadsde®cient mice and is not required for BCR-mediated Ca 2+¯u x or in primary B cell immune responses, therefore the role of Gads in immature and naive B cells remains unde®ned (Yoder et al., 2001) . Interestingly, B cells express BLNK, an adaptor that appears to combine the roles of both LAT and SLP-76 into a single protein (Fu et al., 1998) . This was demonstrated eectively by the ability of exogenous Gads, LAT and SLP-76 co-expression to rescue BCR signalling in a BLNK-de®cient B cell line (Ishiai et al., 2000) .
A role for Gads in monocyte development has been proposed by Bourette and co-workers through demonstration that Gads over-expression in mouse bone marrow cells strongly decreases macrophage development in response to M-CSF (Bourette et al., 1998) . Additionally, in Gads over-expressing myeloid cells, Erk activation is prolonged and enhanced in response to M-CSF stimulation, suggesting that Gads may function downstream of certain RTKs to modify Ras signalling, like its proposed role in T cells (Bourgin et al., 2000) .
The oncogenic 210 kDa Bcr ± Abl protein is associated with chronic myelogenous leukemia (Sawyers, 1999) . Bcr ± Abl mediated transformation is thought to rely on activation of the Ras pathway and evidence suggests that this involves adaptor proteins such as Grb2, which act to couple Bcr ± Abl to Sos (Pendergast et al., 1993; Puil et al., 1994; Tauchi et al., 1994) . Like Grb2, Gads is also associated with Bcr ± Abl through its SH2 domain (Liu and McGlade, 1998) , however, Gads does not recruit Sos to this complex, suggesting that Gads may play a role in BCR ± ABL mediated transformation through activation of a distinct signalling pathway.
Research eorts have largely focused on examining the function of Gads in TCR signalling, and recent gene targeting and transgenic experiments in mice have highlighted its importance for T cell development and activation. These endeavors, combined with genetic studies of LAT and SLP-76, as well as the recent discovery of RasGRP, have contributed towards a revised model of TCR signalling which now includes a novel mechanism of Ras activation. Future directions will likely focus on elucidating Gads function in other hematopoietic cell lineages, where Gads-mediated complexes may couple receptors to distinct downstream pathways.
